MESO 9.20$ (-32%)
11.01.21 16:24
#2
Vassago
MESO 13.14$ (+52%)
https://themarketherald.com.au/...th-latest-trial-results-2021-01-11/
12.02.21 17:07
#3
Vassago
MESO 10.63$ (-3%)
Mesoblast berichtet über positive Ergebnisse im Spätstadium der Stammzelltherapie zur Behandlung chronischer Rückenschmerzen
https://www.fool.com/investing/2021/02/11/...d-stock-is-rising-today/
30.04.21 15:02
#4
Balu4u
reduces mortality in COVID-19 under 65
https://themarketherald.com.au/...-ards-patients-under-65-2021-04-30/
